<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="47">
  <stage>Registered</stage>
  <submitdate>20/07/2005</submitdate>
  <approvaldate>22/07/2005</approvaldate>
  <actrnumber>ACTRN12605000034639</actrnumber>
  <trial_identification>
    <studytitle>Does a single oral dose of dexamethasone after successful emergency department treatment of migraine reduce the incidence or severity of rebound headache within 48 hours?</studytitle>
    <scientifictitle>Does a single oral dose of dexamethasone after successful emergency department treatment of migraine reduce the incidence or severity of rebound headache within 48 hours?</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Migraine</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The primary aim is to compare the proportion of patients who experience rebound headache within 48 hours after ED treatment of migraine between a group treated with single dose oral dexamethasone 8mg and a group treated with placebo.Secondary aims are to compare headache severity, analgesia/ health service use, adverse events and return to normal functioning between the groups.</interventions>
    <comparator>Placebo</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Proportion of patients who were discharged pain free that have a recurrence of headache within 48 hours</outcome>
      <timepoint>48 hours</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Proportion of patients who were not pain free at discharge whose headache is worse or unchanged within 48 hours</outcome>
      <timepoint>48 hours</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Comparison of headache severity.</outcome>
      <timepoint>At Hospital Discharge</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Analgesia/ health service use</outcome>
      <timepoint>48 hours</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Adverse events and return to normal functioning between the groups.</outcome>
      <timepoint>48 hours</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Consenting adult patients with physician-diagnosed migraine treated in the ED who are willing and able to be contacted between 48-72 hours after discharge for follow-up.</inclusivecriteria>
    <inclusiveminage>17</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Failure to consent. Pregnancy. Allergy to study medication. Findings inconsistent with migraine. Patients requiring hospital admission for further investigation and treatment. Patients with active peptic ulcer disease. Patients with Type 1 diabetes. Patients taking corticosteroids for another condition within 7 days. Active systemic fungal infection. Patients previously enrolled in the study</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Numbered Containers</concealment>
    <sequence>computerised sequence generation (in blocks)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>4/01/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>76</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>The Joseph Epstein Centre for Emergency Medicine Research</primarysponsorname>
    <primarysponsoraddress>The Joseph Epstein Centre for Emergency Medicine Research (JECEMR)
Sunshine Hospital
176 Furlong Rd
St Albans Victoria 3021</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Eirene Lucas Foundation</fundingname>
      <fundingaddress>Melbourne Victoria</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Melbourne Health Research Directorate</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Debra Kerr</name>
      <address>The Joseph Epstein Centre for Emergency Medicine Research
Department of Emergency Medicine
Western Hospital
Gordon St
Footscray VIC 3011</address>
      <phone>+61 3 83456454</phone>
      <fax>+61 3 93184790</fax>
      <email>Debbie.Kerr@wh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Anne-Maree Kelly</name>
      <address>The Joseph Epstein Centre for Emergency Medicine Research
Department of Emergency Medicine
Western Hospital 
Gordon St
Footscray VIC 3011</address>
      <phone>+61 3 83456315</phone>
      <fax>+61 3 93184790</fax>
      <email>Anne-Maree.Kelly@wh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Debra Kerr</name>
      <address>JECEMR
Sunshine Hospital
176 Furlong Rd
St Albans Victoria 3021</address>
      <phone>+61 3 83451027</phone>
      <fax>+61 3 83451019</fax>
      <email>Debbie.Kerr@wh.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>